Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.59 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.42 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.42 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.42 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.42 |
| ▸ | PTGFR | P43088 | 3/20 | 0.42 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.41 |
| ▸ | CXCR1 | P25024 | 2/20 | 0.41 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.41 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | RARB | P10826 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1716473 | 0.80 | PTGER3 (0.56) | TBXA2RPTGER3PTGER2PTGDRPTGFR | |
| SCHEMBL17748553 | 0.78 | KDM4E (0.50) | PTGER3PTGER2PTGER4CA12CA1 | |
| SCHEMBL17748552 | 0.78 | KDM4E (0.50) | PTGER3PTGER2PTGER4CA12CA1 | |
| SCHEMBL764948 | 0.76 | KDM4E (0.61) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL7825300 | 0.76 | KDM4E (0.61) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL3637307 | 0.74 | EGFR (1.00) | EGFRTBXA2RPTGER3PTGER2PTGDR | |
| SCHEMBL3637308 | 0.74 | EGFR (1.00) | EGFRTBXA2RPTGER3PTGER2PTGDR | |
| SCHEMBL7138830 | 0.73 | EGFR (0.59) | EGFRTBXA2RPTGER3PTGER2PTGDR | |
| SCHEMBL25146586 | 0.72 | SMN1; SMN2 (0.56) | PTGS1PTGS2LMNACYP2C9AKR1C3 | |
| SCHEMBL25146563 | 0.72 | SMN1; SMN2 (0.56) | PTGS1PTGS2LMNACYP2C9AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070079446-A1 | Stabilized body care products, household products, textiles and fabrics | CIBA SPECIALTY CHEMICALS CORP. | 2007-04-12 | — | — | US | claimed |
| EP-1680541-A2 | STABILIZED BODY CARE PRODUCTS, HOUSEHOLD PRODUCTS, TEXTILES AND FABRICS | Ciba SC Holding AG (CH) | 2006-07-19 | — | — | EP | claimed |
| WO-2005042828-A2 | STABILIZED BODY CARE PRODUCTS, HOUSEHOLD PRODUCTS, TEXTILES AND FABRICS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-05-12 | — | — | WO | claimed |
| EP-0893119-B1 | UV-protection formulation | CIBA SC HOLDING AG (CH) | 2003-09-03 | — | — | EP | claimed |
| US-11918672-B2 | Water based concentrated product forms of oil-soluble organic UV absorbers | BASF SE (DE) | 2024-03-05 | — | — | US | disclosed |
| CN-111050742-B | Water-based concentrated product forms of oil-soluble organic ultraviolet absorbers | 巴斯夫欧洲公司 | 2023-06-30 | — | — | CN | disclosed |
| US-20200337974-A1 | WATER BASED CONCENTRATED PRODUCT FORMS OF OIL-SOLUBLE ORGANIC UV ABSORBERS | BASF SE (DE) | 2020-10-29 | — | — | US | disclosed |
| CN-106999894-B | Microcapsules | 巴斯夫欧洲公司 | 2020-09-29 | — | — | CN | disclosed |
| EP-3227016-B1 | MICROCAPSULES | BASF SE (DE) | 2020-08-26 | — | — | EP | disclosed |
| US-10709645-B2 | Microcapsules | BASF SE (DE) | 2020-07-14 | — | — | US | disclosed |
| EP-3675808-A1 | WATER BASED CONCENTRATED PRODUCT FORMS OF OIL-SOLUBLE ORGANIC UV ABSORBERS | BASF SE (DE) | 2020-07-08 | — | — | EP | disclosed |
| CN-111050742-A | Water-based concentrated product form of oil-soluble organic UV absorber | 巴斯夫欧洲公司 | 2020-04-21 | — | — | CN | disclosed |
| EP-1187598-A1 | MICROPIGMENT MIXTURE | Ciba SC Holding AG (CH) | 2002-03-20 | — | — | EP | disclosed |
| WO-2001051013-A2 | USE OF MICROBIALLY ENCAPSULATED MATERIALS IN COSMETIC END FORMULATIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-07-19 | — | — | WO | disclosed |
| US-6221342-B1 | PROTECTING HUMAN AND ANIMAL SKIN AND HAIR FROM THE DAMAGING EFFECT OF UV RADIATION | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-04-24 | — | — | US | disclosed |
| EP-1068866-A2 | Use of mixtures of micropigments for prevening tannig and to induce skin and hair lightening | Ciba SC Holding AG (CH) | 2001-01-17 | — | — | EP | disclosed |
| WO-2000078277-A1 | MICROPIGMENT MIXTURE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-12-28 | — | — | WO | disclosed |
| EP-1005325-A1 | COSMETIC USE OF BIS(RESORCINYL)TRIAZINE DERIVATIVES | Ciba SC Holding AG (CH) | 2000-06-07 | — | — | EP | disclosed |
| EP-0956851-A1 | Use of nanotopes in cosmetic products | Ciba SC Holding AG (CH) | 1999-11-17 | — | — | EP | disclosed |
| WO-1999008653-A1 | COSMETIC USE OF BIS(RESORCINYL)TRIAZINE DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070079446-A1 | Stabilized body care products, household products, textiles and fabrics | CUTA, NISCH, DSC1 | EGFR 1870/4885GABRA1 4089/4885GABRB2 4345/4885 |
| US-10709645-B2 | Microcapsules | ADH5, IPMK, CHKB | EGFR 4276/4885GABRA1 2863/4885GABRB2 2443/4885 |
| US-20200337974-A1 | WATER BASED CONCENTRATED PRODUCT FORMS OF OIL-SOLUBLE ORGANIC UV ABSORBERS | SSRP1, ACMSD, TST | EGFR 3505/4885GABRA1 823/4885GABRB2 1059/4885 |
| US-11918672-B2 | Water based concentrated product forms of oil-soluble organic UV absorbers | TST, SSRP1, SUPT16H | EGFR 3542/4885GABRA1 902/4885GABRB2 1090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.